Correlation Between Tcr2 Therapeutics and Travere Therapeutics
Can any of the company-specific risk be diversified away by investing in both Tcr2 Therapeutics and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tcr2 Therapeutics and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tcr2 Therapeutics and Travere Therapeutics, you can compare the effects of market volatilities on Tcr2 Therapeutics and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tcr2 Therapeutics with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tcr2 Therapeutics and Travere Therapeutics.
Diversification Opportunities for Tcr2 Therapeutics and Travere Therapeutics
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Tcr2 and Travere is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Tcr2 Therapeutics and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and Tcr2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tcr2 Therapeutics are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of Tcr2 Therapeutics i.e., Tcr2 Therapeutics and Travere Therapeutics go up and down completely randomly.
Pair Corralation between Tcr2 Therapeutics and Travere Therapeutics
Given the investment horizon of 90 days Tcr2 Therapeutics is expected to generate 1.11 times more return on investment than Travere Therapeutics. However, Tcr2 Therapeutics is 1.11 times more volatile than Travere Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Travere Therapeutics is currently generating about 0.02 per unit of risk. If you would invest 141.00 in Tcr2 Therapeutics on August 27, 2024 and sell it today you would earn a total of 7.00 from holding Tcr2 Therapeutics or generate 4.96% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 18.02% |
| Values | Daily Returns |
Tcr2 Therapeutics vs. Travere Therapeutics
Performance |
| Timeline |
| Tcr2 Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Travere Therapeutics |
Tcr2 Therapeutics and Travere Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tcr2 Therapeutics and Travere Therapeutics
The main advantage of trading using opposite Tcr2 Therapeutics and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tcr2 Therapeutics position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.| Tcr2 Therapeutics vs. Affimed NV | Tcr2 Therapeutics vs. Pieris Pharmaceuticals | Tcr2 Therapeutics vs. ADC Therapeutics SA | Tcr2 Therapeutics vs. Agenus Inc |
| Travere Therapeutics vs. Eliem Therapeutics | Travere Therapeutics vs. HCW Biologics | Travere Therapeutics vs. Scpharmaceuticals | Travere Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |